Clinical trial Recruiting at 2 sites Interventional Ages 18 and up Women only

Compare two pelvic floor stimulation devices to see which helps with urinary incontinence in women

Official title: Randomized Clinical Trial: Electromagnetic Chair Therapy in Female Mixed Urinary Incontinence Compared to Standard Care (Electrostimulation With Biofeedback)

Run by Espacio Gaspar Clinic · NCT07792031 · Data updated 2026-11-12

We’re testing if electromagnetic chair therapy can help women with mixed urinary incontinence as well as standard electrostimulation with biofeedback.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment58 (estimated)
SponsorEspacio Gaspar Clinic
Academic / other
Locations2 sites (Mendoza and 1 other locations)
StatusRecruiting
StartedOctober 20, 2026
Main results expectedSeptember 1, 2027
Study endsDecember 1, 2027
Registry record updatedOctober 23, 2026
Trial IDNCT07792031 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older with a confirmed diagnosis of mixed urinary incontinence for at least 3 months, treatment-naive or not recently treated.

Probably not a fit

Patients with active urinary tract infection, advanced pelvic organ prolapse, recent childbirth, prior incontinence surgery, or contraindications to electromagnetic stimulation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, parallel-group, non-inferiority study will enroll 58 adult women with mixed urinary incontinence, randomizing them 1:1 to receive 12 treatment sessions over six weeks. One group will use the StarFormer electromagnetic chair, and the other will receive standard pelvic-floor electrostimulation with biofeedback. Outcomes will be measured at baseline, week 6, and week 30, with the primary endpoint being the change in average daily urinary incontinence episodes over a three-day bladder diary from baseline to week 6. Secondary outcomes include changes in urgency and stress incontinence episodes, voiding frequency, nocturia, pad use, ICIQ-UI SF scores, patient-reported improvement, responder rates, and urodynamic parameters, along with safety and adherence assessments.

Why it matters

Potential benefit: If successful, the approach could offer an effective non-invasive option for reducing urinary leakage and improving quality of life for women with mixed incontinence.

How similar studies have gone: Prior pelvic-floor stimulation studies show promise for symptom improvement, but this direct non-inferiority comparison with an electromagnetic chair is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women ≥ 18 years of age.
* Diagnosis of mixed urinary incontinence according to the operational definition.
* Symptom duration ≥ 3 months.
* Minimum severity: ≥ 2 total incontinence episodes documented in the baseline 3-day bladder diary up to 5 incontinence episodes
* Treatment-naive:

  * With no pharmacologic treatment for OAB/UI in the previous 8 weeks.
  * With no supervised pelvic floor rehabilitation, electrical stimulation, PTNS, neuromodulation, or prior electromagnetic chair therapy (preferably never, for population homogeneity).
* Ability to complete bladder diaries and questionnaires and attend scheduled visits (and all 12 treatment sessions).
* Signed informed consent.

Exclusion Criteria:

* Active or suspected unresolved urinary tract infection (urinalysis ± culture according to local practice; first episode).
* Uninvestigated macroscopic hematuria.
* Advanced pelvic organ prolapse (POP-Q stage III-IV).
* Pregnancy or postpartum \< 2 months.
* Major neurological disease affecting bladder or urethral function.

Where it's running

  • Espacio Gaspar
    Mendoza, Argentina
    Recruiting
  • Uroclinica
    Mendoza, Argentina
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.